Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Open Access Dissertations and Theses Community
  3. Open Access Dissertations and Theses
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/14139
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorBerti, Paulen_US
dc.contributor.authorBalachandran, Nareshen_US
dc.date.accessioned2014-06-18T17:06:26Z-
dc.date.available2014-06-18T17:06:26Z-
dc.date.created2014-05-07en_US
dc.date.issued2014-10en_US
dc.identifier.otheropendissertations/8969en_US
dc.identifier.other10048en_US
dc.identifier.other5559119en_US
dc.identifier.urihttp://hdl.handle.net/11375/14139-
dc.description.abstract<p>The rise of bacterial infections and increase of antibiotic resistant bacteria has become a major problem in the treatment of bacterial infections. The use and overuse of antibiotics, and the inherent ability of bacteria to adapt to their environment, have lead to the emergence of strains that are resistant to all antibiotics. Ideally, new targets for antibacterial drug therapy would be essential to the virulence of most or all bacteria. That is, antibiotics exploiting these targets would have broad spectrum activity. 3-Deoxy-D-arabinoheptulosonate-7- phosphate (DAHP) synthase could be such a target. This enzyme catalyzes the condensation of erythrose 4-phosphate (E4P) and phoshoenolpyruvate (PEP) to form DAHP. The DAHP synthase-catalyzed reaction is the first committed step in the shikimic acid biosynthetic pathway leading to the aromatic amino acids and other secondary metabolites in all bacteria and some parasites. Inhibition of this enzyme would lead to a depletion of aromatic amino acids within the cell, halting new protein synthesis and killing the cells. Our lab has developed a transition state analogue, DAHP oxime, which is a slow binding, potent inhibitor of DAHP synthase. Kinetic characterization of inhibitor binding revealed DAHP oxime to be a competitive inhibitor with an ultimate Ki* of 81 nM. Crystal structures of DAHP oxime bound to DAHP synthase revealed that the inhibitor bound to two of the four subunits. The two unbound subunits remain catalytically competent, suggesting that DAHP synthase may utilize a half-of-sites mechanism during catalysis. We further investigated changes in DAHP synthase dynamics in response to PEP and DAHP oxime binding via solvent hydrogen/deuterium exchange mass spectrometry. DAHP synthase in the unbound form was loosely structured around the surface exposed regions, whereas the X-ray crystal structures appeared to be more fully structured. Binding of both PEP and DAHP oxime introduced different degrees of dynamic stabilization.</p>en_US
dc.subjectenzyme kineticsen_US
dc.subjectmechanismen_US
dc.subjectdrug designen_US
dc.subjectx-ray crystallographyen_US
dc.subjectenzyme dynamicsen_US
dc.subjectBiochemistryen_US
dc.subjectBiochemistryen_US
dc.titleDAHP Oxime: A Transition State Mimic Inhibitor Of DAHP Synthaseen_US
dc.typethesisen_US
dc.contributor.departmentChemical Biologyen_US
dc.description.degreeDoctor of Philosophy (PhD)en_US
Appears in Collections:Open Access Dissertations and Theses

Files in This Item:
File SizeFormat 
fulltext.pdf
Open Access
16.14 MBAdobe PDFView/Open
Show simple item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue